XML 51 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair value of financial instruments - Rollforward of Level 3 liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Mar. 31, 2017
Rollforward of Level 3 liabilities      
Change in fair value of contingent consideration $ 6,685   $ 7,356
ARIAD Pharmaceuticals      
Rollforward of Level 3 liabilities      
Contingent consideration earned during the period but not yet paid (6,700) $ 6,600  
Fair Value | Level 3      
Rollforward of Level 3 liabilities      
Balance at beginning of period 287,000    
Contingent consideration earned during the period but not yet paid (6,685)    
Change in fair value of contingent consideration 6,685    
Balance at end of period $ 287,000 $ 287,000